Oral Cancer Screening with VELscope
Oral cancer strikes three times as many people as cervical cancer. It is one of the few types of cancer that has not seen a significant reduction in incidence over the past 30 years. Recent research as shown a strong association between Human Papilloma Virus (HPV), which can be sexually transmitted, and oral cancer. For this reason, we believe that all patients age 18 or older should have an oral cancer screening once every year.
The FDA recently approved the VELscope system for dentists to scan patients for pre-cancerous or cancerous growths that may not be visible to the naked eye. A screening with VELscope adds about a minute to the comprehensive exam and is completely painless.
Oral cancer is typically discovered in the late stages, when the 5-year survival rate is only 22%. VELscope can detect abnormal growths in the early stages, where the 5-year survival rate is 80%.